Lv21
190 积分 2025-04-01 加入
MAFLD as a predictor of adverse cardiovascular events among CHD patients with LDL-C<1.8 mmol/L
13天前
已完结
Liver Fibrosis and the Risk of Coronary Artery Disease, Stent Thrombosis, Restenosis and Adverse Clinical Outcomes
20天前
已完结
Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
3个月前
已完结
The association of hepatic steatosis and fibrosis with heart failure and mortality
4个月前
已完结
Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
4个月前
已完结
Current Burden of MASLD, MetALD, and Hepatic Fibrosis among US Adults with Prediabetes and Diabetes, 2017-2023
4个月前
已完结
Current Burden of Lean Metabolic Dysfunction‐Associated Steatotic Liver Disease Among US Adults, 2017–2023
4个月前
已完结
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
4个月前
已完结
Liver stiffness as a cornerstone in heart disease risk assessment
4个月前
已完结
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
4个月前
已完结
皖公网安备34019202002308
